Biosynex SA (EPA:ALBIO)
1.180
-0.050 (-4.07%)
Jun 17, 2025, 2:39 PM CET
Biosynex Revenue
In the year 2024, Biosynex had annual revenue of 101.17M EUR with 8.81% growth. Biosynex had revenue of 47.43M in the half year ending December 31, 2024, a decrease of -12.73%.
Revenue
101.17M
Revenue Growth
+8.81%
P/S Ratio
0.23
Revenue / Employee
212.54K
Employees
476
Market Cap
23.06M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 101.17M | 8.19M | 8.81% |
Dec 31, 2023 | 92.98M | -103.61M | -52.70% |
Dec 31, 2022 | 196.59M | -185.95M | -48.61% |
Dec 31, 2021 | 382.53M | 228.64M | 148.57% |
Dec 31, 2020 | 153.90M | 118.72M | 337.54% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
EssilorLuxottica Société anonyme | 26.51B |
Sanofi | 45.17B |
Sartorius Stedim Biotech | 2.86B |
bioMérieux | 3.98B |
Eurofins Scientific SE | 6.95B |
Ipsen | 3.57B |
Virbac | 1.40B |
emeis Société anonyme | 5.64B |